DE871434T1 - 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen - Google Patents

5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen

Info

Publication number
DE871434T1
DE871434T1 DE0871434T DE96943884T DE871434T1 DE 871434 T1 DE871434 T1 DE 871434T1 DE 0871434 T DE0871434 T DE 0871434T DE 96943884 T DE96943884 T DE 96943884T DE 871434 T1 DE871434 T1 DE 871434T1
Authority
DE
Germany
Prior art keywords
asa
diseases
colonal
treating
modified release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE0871434T
Other languages
German (de)
English (en)
Inventor
Svenn JEPSEN
Soeren Halskov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmaceutisk Laboratorium Ferring AS
Original Assignee
Farmaceutisk Laboratorium Ferring AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE871434(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Farmaceutisk Laboratorium Ferring AS filed Critical Farmaceutisk Laboratorium Ferring AS
Publication of DE871434T1 publication Critical patent/DE871434T1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE0871434T 1995-12-21 1996-12-23 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen Pending DE871434T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57595495A 1995-12-21 1995-12-21
PCT/DK1996/000551 WO1997023199A1 (fr) 1995-12-21 1996-12-23 Composition pharmaceutique orale a liberation modifiee contenant 5-asa et procede de traitement de maladies intestinales

Publications (1)

Publication Number Publication Date
DE871434T1 true DE871434T1 (de) 2001-04-05

Family

ID=24302375

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0871434T Pending DE871434T1 (de) 1995-12-21 1996-12-23 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen
DE69615400T Expired - Lifetime DE69615400T3 (de) 1995-12-21 1996-12-23 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69615400T Expired - Lifetime DE69615400T3 (de) 1995-12-21 1996-12-23 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen

Country Status (28)

Country Link
EP (1) EP0871434B2 (fr)
JP (1) JP4714836B2 (fr)
KR (2) KR100598714B1 (fr)
CN (1) CN1155369C (fr)
AT (1) ATE205704T1 (fr)
AU (1) AU702934B2 (fr)
BG (1) BG63484B1 (fr)
BR (1) BR9612213A (fr)
CA (1) CA2240281C (fr)
CZ (1) CZ289290B6 (fr)
DE (2) DE871434T1 (fr)
DK (1) DK0871434T4 (fr)
EE (1) EE03740B1 (fr)
ES (1) ES2149733T5 (fr)
HK (1) HK1017615A1 (fr)
HU (1) HU228856B1 (fr)
IL (1) IL124858A (fr)
IS (1) IS1834B (fr)
NO (1) NO320498B1 (fr)
NZ (1) NZ325201A (fr)
PL (1) PL186790B1 (fr)
PT (1) PT871434E (fr)
RU (1) RU2181043C2 (fr)
SI (1) SI0871434T2 (fr)
SK (1) SK282669B6 (fr)
TR (1) TR199801158T2 (fr)
UA (1) UA67721C2 (fr)
WO (1) WO1997023199A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
DK1146862T3 (da) 1999-01-29 2003-07-21 Disphar Int Bv Farmaceutiske sammensætninger
CA2359812C (fr) 2000-11-20 2004-02-10 The Procter & Gamble Company Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
MXPA04003506A (es) * 2001-10-15 2004-07-23 Ferring Bv Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
US8282955B2 (en) * 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
JP2007523664A (ja) * 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
EP1547601A1 (fr) 2003-12-23 2005-06-29 Ferring B.V. Procédé de revêtement
RU2297835C1 (ru) 2005-09-26 2007-04-27 Закрытое акционерное общество "Партнер" Препарат для лечения неинфекционных воспалительных болезней кишечника
JP5450053B2 (ja) * 2006-04-13 2014-03-26 ニューロテック ファーマシューティカルズ カンパニー リミテッド 細胞損傷及び炎症疾患の治療または予防用薬学組成物
US8569375B2 (en) * 2008-08-22 2013-10-29 Reckitt Benckiser Healthcare (Uk) Limited Compositions
AU2009298139B2 (en) 2008-10-03 2015-02-19 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
EP2340812A1 (fr) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules pour préparations pharmaceutiques, procédés et appareil pour leur production
RU2463055C2 (ru) * 2011-01-12 2012-10-10 Петр Леонидович Щербаков Способ лечения воспалительных заболеваний кишечника
CN102319218B (zh) * 2011-09-22 2014-10-01 贝沃特医药技术(上海)有限公司 一种治疗肠道疾病的药物缓控释微粒制剂及其制备方法
WO2013144176A1 (fr) 2012-03-30 2013-10-03 Laboratorios Del Dr. Esteve, S.A. Formulation à libération contrôlée comprenant de la mésalamine
RU2752082C1 (ru) * 2020-09-29 2021-07-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Башкирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство с гранулами, содержащими 5-аминосалициловую кислоту и фолиевую кислоту, с контролируемым высвобождением

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (fr) * 1980-03-20 1981-10-01 Ferring Farma Lab Composition pharmaceutique et methode de traitement de la colite ulcereuse et la maladie de crohn par voie orale
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
CZ289290B6 (cs) 2001-12-12
SK83498A3 (en) 1999-01-11
BG63484B1 (bg) 2002-03-29
IL124858A (en) 2003-03-12
BG102556A (en) 1999-02-26
PL186790B1 (pl) 2004-02-27
EE03740B1 (et) 2002-06-17
NZ325201A (en) 1998-11-25
UA67721C2 (en) 2004-07-15
HUP0001084A3 (en) 2000-12-28
JP4714836B2 (ja) 2011-06-29
CN1155369C (zh) 2004-06-30
JPH11510191A (ja) 1999-09-07
AU1366197A (en) 1997-07-17
AU702934B2 (en) 1999-03-11
TR199801158T2 (xx) 1998-09-21
DE69615400T3 (de) 2008-08-07
KR19990076584A (ko) 1999-10-15
PL327323A1 (en) 1998-12-07
IL124858A0 (en) 1999-01-26
ES2149733T5 (es) 2008-05-01
NO982904D0 (no) 1998-06-22
IS4772A (is) 1998-06-15
HK1017615A1 (en) 1999-11-26
CA2240281A1 (fr) 1997-07-03
RU2181043C2 (ru) 2002-04-10
IS1834B (is) 2002-11-15
ATE205704T1 (de) 2001-10-15
CZ194698A3 (cs) 1998-10-14
NO982904L (no) 1998-06-22
ES2149733T1 (es) 2000-11-16
KR100598714B1 (ko) 2006-07-10
BR9612213A (pt) 1999-12-28
DK0871434T4 (da) 2008-04-07
EP0871434B2 (fr) 2007-12-12
NO320498B1 (no) 2005-12-12
EE9800191A (et) 1998-12-15
EP0871434B1 (fr) 2001-09-19
SI0871434T2 (sl) 2008-04-30
PT871434E (pt) 2002-02-28
ES2149733T3 (es) 2002-04-01
SK282669B6 (sk) 2002-11-06
KR100542544B1 (ko) 2006-05-10
DK0871434T3 (da) 2002-01-07
CA2240281C (fr) 2007-02-27
DE69615400D1 (de) 2001-10-25
HUP0001084A2 (hu) 2000-11-28
EP0871434A1 (fr) 1998-10-21
DE69615400T2 (de) 2002-05-23
KR20050087886A (ko) 2005-08-31
HU228856B1 (en) 2013-06-28
CN1207672A (zh) 1999-02-10
SI0871434T1 (en) 2002-04-30
WO1997023199A1 (fr) 1997-07-03

Similar Documents

Publication Publication Date Title
DE69615400D1 (de) 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen
RU95109905A (ru) Композиции в жидком, полутвердом, твердом, гелеобразном или пастообразном виде и способ лечения заболеваний полости рта
DE69634776D1 (de) Verwendung eines r-nsaid als chemoschützendes mittel zur behandlung kolorektales krebs
DE69634693D1 (de) Mehrfach ungesättigte omega-3 fettsäuren zur behandlung von entzündlichen darmerkrankungen in kapseln mit zeitabhängiger freisetzung
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
DE69636343D1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
DE69025271T2 (de) Pharmazeutische Zubereitungen mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen
DK0497956T3 (da) Præparater med reguleret frigivelse
DE59002748D1 (de) Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
ATE371441T1 (de) Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn
ATE22282T1 (de) Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
ATE12649T1 (de) Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
KR940008688A (ko) 필수지방산에 의해 킬레이트화된 아연정제